Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REPEVAX with concomitant versus non-concomitant VAXIGRIP in adults aged 60 years and older
2010-021068-13Phase 3Completed
- Sponsor
- Sanofi Pasteur MSD S.N.C.
- Start
- Jun 2010
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of Adacel Polio and influenza vaccine in diphtheria, Tetanus, pertussis and 2 more (2 arms), sponsored by Sanofi Pasteur MSD S.N.C. Primary endpoint: Primary immunogenicity endpoint. Started Jun 2010; status: completed.
02
Drugs
Adacel Polioinfluenza vaccine
03
Conditions
diphtheriaTetanuspertussispoliomyelitisinfluenza
Beyond the preview
Go deeper on 2010-021068-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021068-13.